Novo Nordisk's CagriSema, targeting over 20% weight loss, and Eli Lilly's retatrutide, showing a 24% weight reduction in early trials, are notable candidates
Yang Y, Liu R, Sun Y, Wu B, He B, Jia Y, et al
Contributor Information Mark E
This situation would lead to a self-perpetuating cycle, in which the free radicals generated would induce GSH depletion, thus increasing oxidative stress that would reduce antioxidant enzyme levels, which would further reduce GSH synthesis
R.IrwinN
Like any addict, going cold turkey is a real challenge. Separate research published in Obesity Reviews found a lack of robust evidence surrounding nutritional advice and support for people on semaglutide and tirzepatide